CSL Behring

From Verify.Wiki
Jump to: navigation, search

The Commonwealth Serum Laboratories was established in Australia in 1916 to service the health needs of a nation isolated by war. Over the ensuing years CSL provided Australians with rapid access to 20th century medical advances including insulin and penicillin, and vaccines against influenza, polio and other infectious diseases. CSL Limited was incorporated in 1991 and listed on the Australian Securities Exchange (ASX) in 1994.

Since then, CSL has acquired a number of companies. They include: Aventis Behring, which is now known as global biotech leader CSL Behring, U.S. plasma collector Nabi, which helped to form the world's premier plasma collection company in CSL Plasma, the Novartis influenza vaccine business, now integrated and known as Seqirus, the world's second largest influenza vaccines company and Calimmune, a leader in gene-modification and cell delivery technology. Their combined and rich histories make CSL the innovative global leader it is today.

Type Public / Private
Industry Biopharmaceutical Health Care
Headquarters King of Prussia, Pennsylvania, USA
Key people Paul Perreault, CEO and Managing Director of CSL Limited
Number of employees 20,000+



Top 5 Recent Tweets

November 29, 2020ChemstoreGFRP chemical and process tanks’ versatility truly makes them an asset. The pharmaceutical industry depends on chemi… https://t.co/mj9D8jNWAA
November 26, 2020rob_levinCSL Behring scientists in Germany discovered that sodium laureth sulfate – found in many liquid soaps – works on va… https://t.co/Utp3RrWhbd
November 24, 2020aneesabeyExcited and proud to be a part of this partnership! ➡ Urban League and CSL Behring partner to address community nee… https://t.co/nzDi5TwupS

Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history

  • This page has not been verified